Skip to main content

Web Exclusives

Verzenio with Endocrine Therapy FDA Approved for Adjuvant Treatment of Early Breast Cancer

Nivolumab First Immunotherapy Approved for Adjuvant Treatment of Urothelial Carcinoma

Jemperli Another Therapy Approved for Patients with dMMR Recurrent or Advanced Solid Tumors

Brukinsa Approved for Marginal-Zone Lymphoma and for Waldenström’s Macroglobulinemia

Cabometyx Receives FDA Approval for Differentiated Thyroid Cancer

Exkivity Novel Oral Targeted Therapy Approved for Metastatic NSCLC with EGFR Exon 20 Insertion Mutations

Tivdak First Antibody–Drug Conjugate FDA Approved for Recurrent or Metastatic Cervical Cancer

Jakafi a New Treatment Option for Chronic Graft-versus-Host Disease

Welireg FDA Approved for 3 Tumor Types Associated with von Hippel-Lindau Disease

Rezurock Novel Oral Therapy FDA Approved for Chronic Graft-versus-Host Disease

Page 11 of 37
Results 101 - 110 of 362